FGF21 and Huntington disease: Further multicenter studies with stricter quality control measures, larger sample sizes, and longer follow-up period will be required to evaluate the predictive value of FGF21 and to elucidate whether targeting FGF21 and its signaling pathway will be of therapeutic benefit in HD patients.